Plain-English translation of NCT06734221 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the PAK® balloon catheter, a device designed to open blocked arteries in your legs that are restricting blood flow. The balloon is coated with a medication called paclitaxel to help keep the artery open after treatment. This is a minimally invasive procedure—meaning it uses a small catheter instead of major surgery—and the device is already approved and used in standard practice outside of research.
Blockages in leg arteries can cause pain, limited mobility, and serious complications if blood flow isn't restored. While balloon treatment is well-established, researchers want to confirm that this specific coated-balloon version is safe and effective for keeping arteries open long-term.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive the PAK balloon catheter procedure to open your blocked leg artery. A catheter (thin tube) is guided to the blockage site, where the balloon is inflated to open the artery. The medication coating helps reduce the chance the artery will become blocked again. You will be monitored during the procedure and followed up afterward to make sure the treatment is working safely.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Poland
Spain